Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents

Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents

Abstract The high effectiveness of the third dose of BNT162b2 in healthy adolescents against Omicron BA.1 has been reported in some studies, but immune responses conferring this protection are not yet elucidated. In this analysis, our study (NCT04800133) aims to evaluate the humoral and cellular res...

Full description

Bibliographic Details
Main Authors: Xiaofeng Mu, Carolyn A. Cohen, Daniel Leung, Jaime S. Rosa Duque, Samuel M. S. Cheng, Yuet Chung, Howard H. W. Wong, Amos M. T. Lee, Wing Yan Li, Issan Y. S. Tam, Jennifer H. Y. Lam, Derek H. L. Lee, Sau Man Chan, Leo C. H. Tsang, Karl C. K. Chan, John K. C. Li, Leo L. H. Luk, Sara Chaothai, Kelvin K. H. Kwan, Nym Coco Chu, Masashi Mori, Trushar Jeevan, Ahmed Kandeil, Richard J. Webby, Wenwei Tu, Sophie A. Valkenburg, Malik Peiris, Yu Lung Lau
Format: Article
Language:English
Published: Nature Publishing Group 2022-12-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-022-01282-7

Internet

https://doi.org/10.1038/s41392-022-01282-7

Similar Items